IP Library › Assignment 053493/0724
Patent Assignment
Reel/Frame 053493/0724

Change of Address

Recorded: 2020-08-13 Pages: 3
Assignor
DICERNA PHARMACEUTICALS, INC.
Executed: 2020-08-11
Assignee
DICERNA PHARMACEUTICALS, INC.
33 HAYDEN AVE, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties (20)
Beta Catenin Nucleic Acid Inhibitor Molecule
Reducing Beta-Catenin and Ido Expression to Potentiate Immunotherapy
Double-Stranded Nucleic Acid Inhibitor Molecules Modified with Tm-Increasing Nucleotides
Double-Stranded Nucleic Acid Inhibitor Molecules Containing a Triloop
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
Application: 14/518,346 →
Publication: US 2015/0038554
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
Application: 14/518,379 →
Publication: US 2015/0038555
Ligand-Modified Double-Stranded Nucleic Acids
Application: 15/621,395 →
Publication: US 2017/0305956
Methods and Compositions for the Specific Inhibition of Kras by Asymmetric Double-Stranded Rna
Application: 15/800,440 →
Publication: US 2018/0044680
Compositions and Methods for the Treatment of a Beta-Catenin-Associated Disease or Disorder
Application: 16/084,852 →
Publication: US 2019/0070180
Process for Formulating an Anionic Agent
Application: 16/165,760 →
Publication: US 2019/0151461
Amine Cationic Lipids and Uses Thereof
Application: 16/204,053 →
Publication: US 2019/0084965
Compositions Comprising Reversibly Modified Oligonucleotides and Uses Thereof
Application: 16/325,979 →
Publication: US 2019/0177355
4'-Phosphate Analogs and Oligonucleotides Comprising the Same
Application: 16/328,546 →
Publication: US 2019/0177729
Double-Stranded Nucleic Acid Inhibitor Molecules Modified with Tm-Increasing Nucleotides
Application: 16/381,931 →
Publication: US 2019/0316125
Reducing Beta-Catenin Expression to Potentiate Immunotherapy
Application: 16/497,310 →
Publication: US 2020/0377882
Ligand-Modified Double-Stranded Nucleic Acids
Application: 16/555,193 →
Publication: US 2020/0031862
Reducing Beta-Catenin and Ido Expression to Potentiate Immunotherapy
Application: 62/614,206 →
Double-Stranded Nucleic Acid Inhibitor Molecules Modified with Bicyclic Nucleotides
Application: 62/778,755 →
Compositions and Methods for the Treatment of Kras Associated Diseases or Disorders
Application: 62/826,121 →
Double-Stranded Nucleic Acid Inhibitor Molecules with Shortened Sense Strands
Application: 62/842,908 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 25, 2014
From: BROWN, BOB D.
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 034264/0969 →
Assignment of Assignor's Interest Mar 2, 2017
From: BROWN, BOB D.
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 041445/0110 →
Assignment of Assignor's Interest Jul 24, 2017
From: BROWN, BOB D.; WANG, WEIMAN
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 043075/0102 →
Assignment of Assignor's Interest Nov 1, 2017
From: BROWN, BOB D.
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 044004/0766 →
Assignment of Assignor's Interest Jan 10, 2018
From: GANESH, SHANTHI
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 044585/0356 →
Assignment of Assignor's Interest Sep 13, 2018
From: ABRAMS, MARC; GANESH, SHANTHI
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 046870/0352 →
Assignment of Assignor's Interest Oct 19, 2018
From: BROWN, BOB DALE; YING, BO
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 047238/0031 →
Assignment of Assignor's Interest Oct 19, 2018
From: DICERNA PHARMACEUTICALS, INC.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 047238/0085 →
Assignment of Assignor's Interest Feb 15, 2019
From: WANG, WEIMIN; KRISHNAMURTHY, VENKATA
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 048346/0931 →
Assignment of Assignor's Interest Feb 26, 2019
From: WANG, WEIMIN; LI, QINGYI; NAZEF, NAIM
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 048444/0092 →
Assignment of Assignor's Interest Mar 17, 2019
From: GANESH, SHANTHI
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 048618/0279 →
Assignment of Assignor's Interest Mar 29, 2019
From: BROWN, BOB DALE; WANG, WEIMIN; NAZEF, NAIM
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 048743/0170 →
Assignment of Assignor's Interest Apr 9, 2019
From: GANESH, SHANTHI
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 048836/0239 →
Assignment of Assignor's Interest Jul 15, 2019
From: GANESH, SHANTHI
To: DICERNA PHARMACEUTICALS INC.
Reel/Frame 049748/0641 →
Assignment of Assignor's Interest Jul 15, 2019
From: WANG, WEIMIN; NAZEF, NAIM; BROWN, BOB DALE
To: DICERNA PHARMACEUTICALS INC.
Reel/Frame 049748/0804 →
Assignment of Assignor's Interest Jul 15, 2019
From: BROWN, BOB DALE; WANG, WEIMIN
To: DICERNA PHARMACEUTICALS INC.
Reel/Frame 049748/0935 →
Assignment of Assignor's Interest Aug 29, 2019
From: BROWN, BOB D.; WANG, WEIMIN
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 050212/0450 →
Assignment of Assignor's Interest Sep 24, 2019
From: GANESH, SHANTHI; ABRAMS, MARC
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 050477/0856 →
Assignment of Assignor's Interest Jul 28, 2020
From: BROWN, BOB DALE
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 053331/0420 →
Assignment of Assignor's Interest Aug 2, 2020
From: BROWN, BOB DALE
To: DICERNA PHARMACEUTICALS, INC.
Reel/Frame 053377/0551 →
Assignment of Assignor's Interest Apr 14, 2025
From: DICERNA PHARMACEUTICALS, INC.
To: NOVO NORDISK A/S
Reel/Frame 070837/0034 →